More life sciences companies are bringing together their QMS and content management systems on a single cloud platform to drive greater efficiency and visibility across quality processes
PHILADELPHIA — 2017 Veeva Global R&D Summit — Oct. 3, 2017 — Veeva Systems (NYSE: VEEV) announced that Veeva Vault Quality is helping an increasing number of life sciences customers to modernize quality and content management in the cloud. The number of Vault Quality customers has increased to 120, including four of the top 20 largest biopharmaceutical companies and 30 Veeva Vault QMS customers. More life sciences companies are using Vault Quality applications to support their end-to-end processes across internal and external stakeholders for greater visibility and control.
“We wanted our quality system accessible to suppliers beyond our four walls so we could improve quality in the supply chain,” said James Huang, director of global quality systems at Atrium Innovations. “Vault Quality enables us to bring parties together to manage change control more effectively, improve collaboration to solve quality problems, and harmonize different business processes to speed workflows.”
The continued outsourcing of critical manufacturing functions and the high costs of quality issues are prompting companies to improve quality management. Many organizations are moving away from manual processes and system silos to streamline processes across global sites, suppliers, contract manufacturers, and other partners.
Veeva Vault QMS and Veeva Vault QualityDocs are part of Vault Quality, the industry’s first and only unified suite of quality applications for seamless end-to-end quality and content management. Companies are adopting Vault QMS and Vault QualityDocs to standardize the flow of information while ensuring process transparency.
“A major transformation in the life sciences industry is underway to modernize quality applications and processes,” said Mike Jovanis, vice president of Vault Quality at Veeva. “Veeva Vault Quality is replacing disparate legacy systems and making it easier to bring internal and external stakeholders into quality processes with cloud applications that are much easier to use.”
In other news today, Veeva announced that the adoption of Veeva Vault CTMS is gaining momentum with customers needing to unify clinical information and processes across their studies. Read our press release to learn more.
Veeva also announced today its intention to enter the safety market with Veeva Vault Safety. Veeva will develop cloud applications that help pharmacovigilance and safety departments increase efficiency and maintain compliance in managing safety processes. The addition of Vault Safety with Vault Clinical, Vault Quality, and Vault RIM will make Vault Development Cloud the most comprehensive suite of unified cloud applications to help life sciences companies speed drug development. Vault Safety is expected to be available in 2019.
For more on Veeva Vault Quality, visit: veeva.com/VaultQuality
Connect with Veeva on LinkedIn: www.linkedin.com/company/veeva-systems
Follow @veevasystems on Twitter: www.twitter.com/veevasystems
Like Veeva on Facebook: www.facebook.com/veevasystems
About Veeva Systems
Veeva Systems Inc. is a leader in cloud-based software for the global life sciences industry. Committed to innovation, product excellence, and customer success, Veeva has more than 550 customers, ranging from the world’s largest pharmaceutical companies to emerging biotechs. Veeva is headquartered in the San Francisco Bay Area, with offices in Europe, Asia, and Latin America. For more information, visit veeva.com.
This release contains forward-looking statements, including the market demand for and acceptance of Veeva’s products and services, the results from use of Veeva’s products and services, and general business conditions, particularly in the life sciences industry. Any forward-looking statements contained in this press release are based upon Veeva’s historical performance and its current plans, estimates, and expectations, and are not a representation that such plans, estimates, or expectations will be achieved. These forward-looking statements represent Veeva’s expectations as of the date of this press announcement. Subsequent events may cause these expectations to change, and Veeva disclaims any obligation to update the forward-looking statements in the future. These forward-looking statements are subject to known and unknown risks and uncertainties that may cause actual results to differ materially. Additional risks and uncertainties that could affect Veeva’s financial results are included under the captions, “Risk Factors” and “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” in the company’s filing on Form 10-Q for the period ended July 31, 2017. This is available on the company’s website at www.veeva.com under the Investors section and on the SEC’s website at www.sec.gov. Further information on potential risks that could affect actual results will be included in other filings Veeva makes with the SEC from time to time.